お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、胃腸薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に胃腸薬市場を分類しています。
本レポートでは世界の胃腸薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Takeda、AstraZeneca、Bayer、Pfizer、Sun Pharma、Teva、Zeria、Perrigo、Eisai Co.、Abbvie、Jiangzhong、AOSAIKANG Pharma、Luoxin Pharma、LIVZON、Eastchina Pharma、Bausch Health

レポートは胃腸薬の主要生産者を調査し、主要地域や国の消費状況も提供します。胃腸薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Prescription
    OTC

用途別の市場セグメント：
    Inflammatory Bowel Disease
    IBS Disease
    Peptic Ulcer
    GERD
    Other

本レポートの詳細内容
本レポートは、世界の胃腸薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて胃腸薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の胃腸薬生産量、成長率、市場シェアを調査している。

二. 消費面では、胃腸薬の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの胃腸薬売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の胃腸薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本胃腸薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：胃腸薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 胃腸薬の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける胃腸薬の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章胃腸薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：胃腸薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：胃腸薬の主要メーカーの概要を提供し、製品の説明と仕様、胃腸薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：胃腸薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Gastrointestinal (GI) disorder is a functional disorder or disease which occurs when the main abnormality is the way the body works. In the doctor’s office, no structural or biochemical cause is seen. Gastrointestinal problems occur when nerves or muscles in any portion of the digestive tract do not function in a coordinated fashion, or when the sensitivity of the nerves of the intestines or the way in which the brain controls some of these functions is impaired. In this report, we study the drugs for gastrointestinal.
The global Gastrointestinal Drugs market is projected to grow from US$ 43070 million in 2024 to US$ 56420 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.
The key players of Gastrointestinal Drugs include Takeda, AstraZeneca and Bayer, etc. The top three players hold a share over 9%. Asia-Pacific is the largest market, has a share about 25%. In terms of product type, Prescription is the largest segment, occupied for a share of about 64%, and in terms of application, Inflammatory Bowel Disease has a share about 44 percent.
Report Covers:
This report presents an overview of global market for Gastrointestinal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gastrointestinal Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gastrointestinal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Gastrointestinal Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Takeda
    AstraZeneca
    Bayer
    Pfizer
    Sun Pharma
    Teva
    Zeria
    Perrigo
    Eisai Co.
    Abbvie
    Jiangzhong
    AOSAIKANG Pharma
    Luoxin Pharma
    LIVZON
    Eastchina Pharma
    Bausch Health

Segment by Type
    Prescription
    OTC

Segment by Application
    Inflammatory Bowel Disease
    IBS Disease
    Peptic Ulcer
    GERD
    Other

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Gastrointestinal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Prescription
    Table 3. Major Manufacturers of OTC
    Table 4. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Gastrointestinal Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Gastrointestinal Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Gastrointestinal Drugs Revenue Market Share by Region (2019-2024)
    Table 9. Global Gastrointestinal Drugs Revenue Market Share by Region (2025-2030)
    Table 10. Global Gastrointestinal Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Gastrointestinal Drugs Sales by Region (2019-2024) & (M Units)
    Table 12. Global Gastrointestinal Drugs Sales by Region (2025-2030) & (M Units)
    Table 13. Global Gastrointestinal Drugs Sales Market Share by Region (2019-2024)
    Table 14. Global Gastrointestinal Drugs Sales Market Share by Region (2025-2030)
    Table 15. Global Gastrointestinal Drugs Sales by Manufacturers (2019-2024) & (M Units)
    Table 16. Global Gastrointestinal Drugs Sales Share by Manufacturers (2019-2024)
    Table 17. Global Gastrointestinal Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Gastrointestinal Drugs Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Gastrointestinal Drugs Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2023)
    Table 23. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Gastrointestinal Drugs, Product Offered and Application
    Table 25. Global Key Manufacturers of Gastrointestinal Drugs, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Gastrointestinal Drugs Sales by Type (2019-2024) & (M Units)
    Table 28. Global Gastrointestinal Drugs Sales by Type (2025-2030) & (M Units)
    Table 29. Global Gastrointestinal Drugs Sales Share by Type (2019-2024)
    Table 30. Global Gastrointestinal Drugs Sales Share by Type (2025-2030)
    Table 31. Global Gastrointestinal Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Gastrointestinal Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Gastrointestinal Drugs Revenue Share by Type (2019-2024)
    Table 34. Global Gastrointestinal Drugs Revenue Share by Type (2025-2030)
    Table 35. Gastrointestinal Drugs Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Gastrointestinal Drugs Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Gastrointestinal Drugs Sales by Application (2019-2024) & (M Units)
    Table 38. Global Gastrointestinal Drugs Sales by Application (2025-2030) & (M Units)
    Table 39. Global Gastrointestinal Drugs Sales Share by Application (2019-2024)
    Table 40. Global Gastrointestinal Drugs Sales Share by Application (2025-2030)
    Table 41. Global Gastrointestinal Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Gastrointestinal Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Gastrointestinal Drugs Revenue Share by Application (2019-2024)
    Table 44. Global Gastrointestinal Drugs Revenue Share by Application (2025-2030)
    Table 45. Gastrointestinal Drugs Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Gastrointestinal Drugs Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Gastrointestinal Drugs Sales by Type (2019-2024) & (M Units)
    Table 48. US & Canada Gastrointestinal Drugs Sales by Type (2025-2030) & (M Units)
    Table 49. US & Canada Gastrointestinal Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Gastrointestinal Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Gastrointestinal Drugs Sales by Application (2019-2024) & (M Units)
    Table 52. US & Canada Gastrointestinal Drugs Sales by Application (2025-2030) & (M Units)
    Table 53. US & Canada Gastrointestinal Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Gastrointestinal Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Gastrointestinal Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Gastrointestinal Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Gastrointestinal Drugs Sales by Country (2019-2024) & (M Units)
    Table 59. US & Canada Gastrointestinal Drugs Sales by Country (2025-2030) & (M Units)
    Table 60. Europe Gastrointestinal Drugs Sales by Type (2019-2024) & (M Units)
    Table 61. Europe Gastrointestinal Drugs Sales by Type (2025-2030) & (M Units)
    Table 62. Europe Gastrointestinal Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Gastrointestinal Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Gastrointestinal Drugs Sales by Application (2019-2024) & (M Units)
    Table 65. Europe Gastrointestinal Drugs Sales by Application (2025-2030) & (M Units)
    Table 66. Europe Gastrointestinal Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Gastrointestinal Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Gastrointestinal Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Gastrointestinal Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Gastrointestinal Drugs Sales by Country (2019-2024) & (M Units)
    Table 72. Europe Gastrointestinal Drugs Sales by Country (2025-2030) & (M Units)
    Table 73. China Gastrointestinal Drugs Sales by Type (2019-2024) & (M Units)
    Table 74. China Gastrointestinal Drugs Sales by Type (2025-2030) & (M Units)
    Table 75. China Gastrointestinal Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Gastrointestinal Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Gastrointestinal Drugs Sales by Application (2019-2024) & (M Units)
    Table 78. China Gastrointestinal Drugs Sales by Application (2025-2030) & (M Units)
    Table 79. China Gastrointestinal Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Gastrointestinal Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Gastrointestinal Drugs Sales by Type (2019-2024) & (M Units)
    Table 82. Asia Gastrointestinal Drugs Sales by Type (2025-2030) & (M Units)
    Table 83. Asia Gastrointestinal Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Gastrointestinal Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Gastrointestinal Drugs Sales by Application (2019-2024) & (M Units)
    Table 86. Asia Gastrointestinal Drugs Sales by Application (2025-2030) & (M Units)
    Table 87. Asia Gastrointestinal Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Gastrointestinal Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Gastrointestinal Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Gastrointestinal Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Gastrointestinal Drugs Sales by Region (2019-2024) & (M Units)
    Table 93. Asia Gastrointestinal Drugs Sales by Region (2025-2030) & (M Units)
    Table 94. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2019-2024) & (M Units)
    Table 95. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2025-2030) & (M Units)
    Table 96. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2019-2024) & (M Units)
    Table 99. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2025-2030) & (M Units)
    Table 100. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2019-2024) & (M Units)
    Table 106. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2025-2030) & (M Units)
    Table 107. Takeda Company Information
    Table 108. Takeda Description and Major Businesses
    Table 109. Takeda Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Takeda Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Takeda Recent Developments
    Table 112. AstraZeneca Company Information
    Table 113. AstraZeneca Description and Major Businesses
    Table 114. AstraZeneca Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. AstraZeneca Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. AstraZeneca Recent Developments
    Table 117. Bayer Company Information
    Table 118. Bayer Description and Major Businesses
    Table 119. Bayer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Bayer Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Bayer Recent Developments
    Table 122. Pfizer Company Information
    Table 123. Pfizer Description and Major Businesses
    Table 124. Pfizer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Pfizer Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Pfizer Recent Developments
    Table 127. Sun Pharma Company Information
    Table 128. Sun Pharma Description and Major Businesses
    Table 129. Sun Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Sun Pharma Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Sun Pharma Recent Developments
    Table 132. Teva Company Information
    Table 133. Teva Description and Major Businesses
    Table 134. Teva Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Teva Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Teva Recent Developments
    Table 137. Zeria Company Information
    Table 138. Zeria Description and Major Businesses
    Table 139. Zeria Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Zeria Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Zeria Recent Developments
    Table 142. Perrigo Company Information
    Table 143. Perrigo Description and Major Businesses
    Table 144. Perrigo Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Perrigo Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Perrigo Recent Developments
    Table 147. Eisai Co. Company Information
    Table 148. Eisai Co. Description and Major Businesses
    Table 149. Eisai Co. Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Eisai Co. Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Eisai Co. Recent Developments
    Table 152. Abbvie Company Information
    Table 153. Abbvie Description and Major Businesses
    Table 154. Abbvie Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Abbvie Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Abbvie Recent Developments
    Table 157. Jiangzhong Company Information
    Table 158. Jiangzhong Description and Major Businesses
    Table 159. Jiangzhong Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Jiangzhong Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Jiangzhong Recent Developments
    Table 162. AOSAIKANG Pharma Company Information
    Table 163. AOSAIKANG Pharma Description and Major Businesses
    Table 164. AOSAIKANG Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. AOSAIKANG Pharma Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. AOSAIKANG Pharma Recent Developments
    Table 167. Luoxin Pharma Company Information
    Table 168. Luoxin Pharma Description and Major Businesses
    Table 169. Luoxin Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Luoxin Pharma Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Luoxin Pharma Recent Developments
    Table 172. LIVZON Company Information
    Table 173. LIVZON Description and Major Businesses
    Table 174. LIVZON Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. LIVZON Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. LIVZON Recent Developments
    Table 177. Eastchina Pharma Company Information
    Table 178. Eastchina Pharma Description and Major Businesses
    Table 179. Eastchina Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 180. Eastchina Pharma Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Eastchina Pharma Recent Developments
    Table 182. Bausch Health Company Information
    Table 183. Bausch Health Description and Major Businesses
    Table 184. Bausch Health Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 185. Bausch Health Gastrointestinal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 186. Bausch Health Recent Developments
    Table 187. Key Raw Materials Lists
    Table 188. Raw Materials Key Suppliers Lists
    Table 189. Gastrointestinal Drugs Distributors List
    Table 190. Gastrointestinal Drugs Customers List
    Table 191. Gastrointestinal Drugs Market Trends
    Table 192. Gastrointestinal Drugs Market Drivers
    Table 193. Gastrointestinal Drugs Market Challenges
    Table 194. Gastrointestinal Drugs Market Restraints
    Table 195. Research Programs/Design for This Report
    Table 196. Key Data Information from Secondary Sources
    Table 197. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastrointestinal Drugs Product Picture
    Figure 2. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Gastrointestinal Drugs Market Share by Type in 2023 & 2030
    Figure 4. Prescription Product Picture
    Figure 5. OTC Product Picture
    Figure 6. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Gastrointestinal Drugs Market Share by Application in 2023 & 2030
    Figure 8. Inflammatory Bowel Disease
    Figure 9. IBS Disease
    Figure 10. Peptic Ulcer
    Figure 11. GERD
    Figure 12. Other
    Figure 13. Gastrointestinal Drugs Report Years Considered
    Figure 14. Global Gastrointestinal Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Gastrointestinal Drugs Revenue 2019-2030 (US$ Million)
    Figure 16. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Gastrointestinal Drugs Revenue Market Share by Region (2019-2030)
    Figure 18. Global Gastrointestinal Drugs Sales 2019-2030 ((M Units)
    Figure 19. Global Gastrointestinal Drugs Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Gastrointestinal Drugs Sales YoY (2019-2030) & (M Units)
    Figure 21. US & Canada Gastrointestinal Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Gastrointestinal Drugs Sales YoY (2019-2030) & (M Units)
    Figure 23. Europe Gastrointestinal Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Gastrointestinal Drugs Sales YoY (2019-2030) & (M Units)
    Figure 25. China Gastrointestinal Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Gastrointestinal Drugs Sales YoY (2019-2030) & (M Units)
    Figure 27. Asia (excluding China) Gastrointestinal Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Gastrointestinal Drugs Sales YoY (2019-2030) & (M Units)
    Figure 29. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Gastrointestinal Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Gastrointestinal Drugs in the World: Market Share by Gastrointestinal Drugs Revenue in 2023
    Figure 32. Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
    Figure 34. Global Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
    Figure 35. Global Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
    Figure 36. Global Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Gastrointestinal Drugs Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Gastrointestinal Drugs Sales Share by Country (2019-2030)
    Figure 43. U.S. Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
    Figure 46. Europe Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
    Figure 48. Europe Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Gastrointestinal Drugs Revenue Share by Country (2019-2030)
    Figure 50. Europe Gastrointestinal Drugs Sales Share by Country (2019-2030)
    Figure 51. Germany Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 52. France Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 56. China Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
    Figure 57. China Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
    Figure 58. China Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
    Figure 59. China Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
    Figure 61. Asia Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
    Figure 63. Asia Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Gastrointestinal Drugs Revenue Share by Region (2019-2030)
    Figure 65. Asia Gastrointestinal Drugs Sales Share by Region (2019-2030)
    Figure 66. Japan Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 70. India Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Share by Country (2019-2030)
    Figure 77. Brazil Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Gastrointestinal Drugs Revenue (2019-2030) & (US$ Million)
    Figure 82. Gastrointestinal Drugs Value Chain
    Figure 83. Gastrointestinal Drugs Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed